Breaking News
0

Can Rite Aid (RAD) Beat On Earnings In Q1 Despite Soft View?

By Zacks Investment ResearchStock MarketsJun 19, 2019 08:58AM ET
www.investing.com/analysis/can-rite-aid-rad-beat-on-earnings-in-q1-despite-soft-view-200432827
Can Rite Aid (RAD) Beat On Earnings In Q1 Despite Soft View?
By Zacks Investment Research   |  Jun 19, 2019 08:58AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Rite Aid Corporation (NYSE:RAD) is slated to report first-quarter fiscal 2020 results on Jun 26. The company pulled off positive bottom-line surprises in the last two quarters. Its average beat is 77.2% for the trailing four quarters.

The Zacks Consensus Estimate for the fiscal first-quarter earnings is pegged at 2 cents, whereas it witnessed loss per share of 20 cents in the year-ago quarter. Estimates remained unchanged in the last 30 days. Further, the consensus estimate for revenues stands at $5.37 billion, which suggests a decline of 0.3% from the year-ago reported figure.

Let’s see how things are shaping up prior to this announcement.

Factors at Play

Rite Aid is progressing well on its growth strategy, which focuses on leveraging unique opportunities such as EnvisionRxOptions PBM, enhancing front-end channels and transforming processes to deliver operational efficiency. Further, the company is focused on leveraging retail pharmacies as well as health and wellness offerings. These efforts have significantly contributed to the company’s top and bottom-line growth in the past, which is likely to be reflected again in the upcoming quarterly results.

The company’s quarterly results also validated strong progress in boosting retail and pharmacy benefits management businesses through a successful immunization business and other clinical pharmacy services. This has resulted in significant rise in the prescription count at comparable stores as well as increased prescription sales over the past several quarters. With continued strength in retail and pharmacy sales, we expect this trend to continue in the first quarter of fiscal 2020.

Furthermore, with a view to capturing the demand for CBD products, the company plans to start selling CBD creams, lotions and lip balms at stores in Oregon and Washington, beginning April 2019.

Additionally, the company remains keen on boosting customer experience, both online and in-store, as part of its efforts to boost market share. It has been doing this through the remodeling of wellness stores. Further, the company shifted e-commerce fulfillment from a third-party provider to its own distribution network to boost customer experience. This has reduced fulfillment lead time, lowered costs and helped to increase online offerings by 25%. These actions should again bolster top-line growth in the to-be-reported quarter.

However, the company’s soft outlook for fiscal 2020 is a cause of concern for investors. Revenues are anticipated to be $21.5-$21.9 billion for fiscal 2020. Further, it now envisions the bottom line between loss of 1 cent per share and earnings of 4 cents.

Further, softness in tobacco sales, owing to regulation changes, which restricted selling tobacco in some New York stores and in over-the-counter cough-cold and flu products, is affecting front-end sales. This along with higher expenses in distribution centers, particularly higher labor costs due to the aforementioned realignment of stores, hurt overall gross profit in fourth-quarter fiscal 2019. Persistence of these headwinds may be a threat to the company’s margins again in first-quarter fiscal 2020.

A Look at the Zacks Model

Our proven model does not conclusively predict that Rite Aid is likely to beat estimates this quarter. This is because a stock needs to have — a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) — for this to happen. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Rite Aid currently has a Zacks Rank #2, which increases chances of an earnings beat. But its Earnings ESP of 0.00% makes surprise prediction difficult.

Stocks Poised to Beat Earnings Estimates

Here are some companies that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat:

Constellation Brands Inc (NYSE:STZ) currently has an Earnings ESP of +4.42% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

Helen of Troy Limited (NASDAQ:HELE) presently has an Earnings ESP of +0.60% and a Zacks Rank #2.

Darden Restaurants, Inc. (NYSE:DRI) currently has an Earnings ESP of +1.16% and a Zacks Rank #3.

This Could Be the Fastest Way to Grow Wealth in 2019

Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.

These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.

Click here to see these breakthrough stocks now >>



Constellation Brands Inc (STZ): Free Stock Analysis Report

Helen of Troy Limited (HELE): Free Stock Analysis Report

Rite Aid Corporation (RAD): Free Stock Analysis Report

Darden Restaurants, Inc. (DRI): Free Stock Analysis Report

Original post

Zacks Investment Research
Can Rite Aid (RAD) Beat On Earnings In Q1 Despite Soft View?
 
Can Rite Aid (RAD) Beat On Earnings In Q1 Despite Soft View?

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email